Pharmacological treatments in pregnant women with psoriasis in the U.S.A.
dc.contributor.author | Lin, H.C. | en_US |
dc.contributor.author | Hunnicutt, J.N. | en_US |
dc.contributor.author | Moustafa, F.A. | en_US |
dc.contributor.author | Rohr, A.L. | en_US |
dc.contributor.author | Huang, K.E. | en_US |
dc.contributor.author | Balkrishnan, R. | en_US |
dc.contributor.author | Feldman, S.R. | en_US |
dc.date.accessioned | 2015-04-02T15:12:37Z | |
dc.date.available | 2016-05-10T20:26:28Z | en |
dc.date.issued | 2015-03 | en_US |
dc.identifier.citation | Lin, H.C.; Hunnicutt, J.N.; Moustafa, F.A.; Rohr, A.L.; Huang, K.E.; Balkrishnan, R.; Feldman, S.R. (2015). "Pharmacological treatments in pregnant women with psoriasis in the U.S.A.." British Journal of Dermatology 172(3): 807-810. | en_US |
dc.identifier.issn | 0007-0963 | en_US |
dc.identifier.issn | 1365-2133 | en_US |
dc.identifier.uri | https://hdl.handle.net/2027.42/110872 | |
dc.publisher | Wiley Periodicals, Inc. | en_US |
dc.title | Pharmacological treatments in pregnant women with psoriasis in the U.S.A. | en_US |
dc.type | Article | en_US |
dc.rights.robots | IndexNoFollow | en_US |
dc.subject.hlbsecondlevel | Dermatology | en_US |
dc.subject.hlbtoplevel | Health Sciences | en_US |
dc.description.peerreviewed | Peer Reviewed | en_US |
dc.description.bitstreamurl | http://deepblue.lib.umich.edu/bitstream/2027.42/110872/1/bjd13306.pdf | |
dc.identifier.doi | 10.1111/bjd.13306 | en_US |
dc.identifier.source | British Journal of Dermatology | en_US |
dc.identifier.citedreference | Bae YS, Van Voorhees AS, Hsu S et al. Review of treatment options for psoriasis in pregnant or lactating women: from the Medical Board of the National Psoriasis Foundation. J Am Acad Dermatol 2012; 67: 459 – 77. | en_US |
dc.identifier.citedreference | Chi CC, Lee CW, Wojnarowska F, Kirtschig G. Safety of topical corticosteroids in pregnancy. Cochrane Database Syst Rev 2009; 3: CD007346. | en_US |
dc.identifier.citedreference | Babalola O, Strober BE. Management of psoriasis in pregnancy. Dermatol Ther 2013; 26: 285 – 92. | en_US |
dc.identifier.citedreference | Strauss LT, Gamble SB, Parker WY et al. Abortion surveillance – United States, 2004. MMWR Surveill Summ 2007; 56: 1 – 33. | en_US |
dc.identifier.citedreference | Hornbrook MC, Whitlock EP, Berg CJ et al. Development of an algorithm to identify pregnancy episodes in an integrated health care delivery system. Health Serv Res 2007; 42: 908 – 27. | en_US |
dc.identifier.citedreference | Kuklina EV, Whiteman MK, Hillis SD et al. An enhanced method for identifying obstetric deliveries: implications for estimating maternal morbidity. Matern Child Health J 2008; 12: 469 – 77. | en_US |
dc.identifier.citedreference | Parisi R, Symmons DP, Griffiths CE, Ashcroft DM. Global epidemiology of psoriasis: a systematic review of incidence and prevalence. J Invest Dermatol 2013; 133: 377 – 85. | en_US |
dc.identifier.citedreference | Weatherhead S, Robson SC, Reynolds NJ. Management of psoriasis in pregnancy. BMJ 2007; 334: 1218 – 20. | en_US |
dc.identifier.citedreference | Horn EJ, Chambers CD, Menter A, Kimball AB. Pregnancy outcomes in psoriasis: why do we know so little? J Am Acad Dermatol 2009; 61: e5 – 8. | en_US |
dc.identifier.citedreference | Murase JE, Heller MH, Butler DC. Safety of dermatologic medications in pregnancy and lactation: part I. Pregnancy. J Am Acad Dermatol 2014; 70: 401.e1 – 14. | en_US |
dc.owningcollname | Interdisciplinary and Peer-Reviewed |
Files in this item
Remediation of Harmful Language
The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.
Accessibility
If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.